Amoxycillin + Clavulanic Acid in pharma franchise in Maharashtra

Amoxycillin + Clavulanic Acid in PCD pharma franchise in Shillong

Amoxycillin + Clavulanic Acid in top pharma company in Varanasi

Amoxycillin + Clavulanic Acid in pcd pharma supplier in Coimbatore

Amoxycillin + Clavulanic Acid in phama franchise company in India
Amoxycillin + Clavulanic Acid in phama distributor in Visakhapatnam

Home/Products /amoxycillin-875mg-clavulanic-acid-125mg-tablet

Moxyplit CV 1000 Tablet

Composition : Amoxycillin (875mg) + Clavulanic Acid (125mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*1*10

Price : ₹491/-

Moxyplit CV 1000 Tablet combines the potent antibiotic Amoxycillin with Clavulanic Acid to effectively treat a wide range of bacterial infections. Amoxycillin works by inhibiting the synthesis of bacterial cell walls, leading to cell death. However, many bacteria produce beta-lactamase, an enzyme that can render Amoxycillin ineffective. To combat this, Clavulanic Acid is included to inhibit beta-lactamase, enhancing the effectiveness of Amoxycillin against resistant bacteria.

This combination is commonly used to treat bacterial infections in the respiratory tract (such as pneumonia, bronchitis), skin and soft tissue infections, urinary tract infections, and ear infections. It is also effective in treating intra-abdominal infections and infections caused by susceptible organisms in both adults and children.

Moxyplit CV 1000 Tablet not only combats the infection effectively but also minimizes the likelihood of developing antibiotic resistance. It falls under the Antibiotic and Antibacterials categories and is widely used in General and Gastroenterology therapeutic areas.

Read More

About the Product

Moxyplit CV 1000 Tablet combines the potent antibiotic Amoxycillin with Clavulanic Acid to effectively treat a wide range of bacterial infections. Amoxycillin works by inhibiting the synthesis of bacterial cell walls, leading to cell death. However, many bacteria produce beta-lactamase, an enzyme that can render Amoxycillin ineffective. To combat this, Clavulanic Acid is included to inhibit beta-lactamase, enhancing the effectiveness of Amoxycillin against resistant bacteria.

This combination is commonly used to treat bacterial infections in the respiratory tract (such as pneumonia, bronchitis), skin and soft tissue infections, urinary tract infections, and ear infections. It is also effective in treating intra-abdominal infections and infections caused by susceptible organisms in both adults and children.

Moxyplit CV 1000 Tablet not only combats the infection effectively but also minimizes the likelihood of developing antibiotic resistance. It falls under the Antibiotic and Antibacterials categories and is widely used in General and Gastroenterology therapeutic areas.

Common side effects associated with Moxyplit CV 1000 Tablet may include nausea, diarrhea, vomiting, fungal infections (in areas such as the mouth, skin folds, or vagina), skin rashes, and vaginitis.

Moxyplit CV 1000 Tablet Indicated for treating bacterial infections of the lungs, ear, nasal sinuses, urinary tract, skin, and soft tissues.

Information regarding the use of Moxyplit CV 1000 Tablet during breastfeeding is not available. Please consult your doctor.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation